Hepatitis B virus variants with lamivudine-related mutations in the DNA polymerase and the ‘a’ epitope of the surface antigen are sensitive to ganciclovir
- 30 April 1999
- journal article
- case report
- Published by Elsevier in Antiviral Research
- Vol. 41 (3) , 113-118
- https://doi.org/10.1016/s0166-3542(99)00007-8
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Current aspects of hepatitis B surface antigen mutants in SingaporeJournal of Viral Hepatitis, 1998
- Hepatitis B virus surface antigen and polymerase gene variants: Potential virological and clinical significanceHepatology, 1998
- The prevalence of surface antigen variants of hepatitis B virus in Papua New Guinea, South Africa, and SardiniaHepatology, 1997
- Lamivudine resistance inimmunocompetent chronic hepatitis BJournal of Hepatology, 1997
- Hepatitis-B-virus resistance to lamivudine given for recurrent infection after orthotopic liver transplantationThe Lancet, 1997
- Lamivudine Is Effective in Suppressing Hepatitis B Virus Dna in Chinese Hepatitis B Surface Antigen Carriers: A Placebo–Controlled TrialHepatology, 1997
- Molecular epidemiology of hepatitis B virus vaccine variants in SingaporeVaccine, 1995
- A Preliminary Trial of Lamivudine for Chronic Hepatitis B InfectionNew England Journal of Medicine, 1995
- Fulminant reactivation of hepatitis B due to envelope protein mutant that escaped detection by monoclonal HBsAg ELISAThe Lancet, 1995